STAT3 and cancer: To further investigate the connection between STAT1, STAT3 and said cytokines in drug resistance, we have treated cells (EP and LP) with cytokine-neutralized (IL-6, IL-10 and IL-1β) MDSC supernatant (in presence or absence of these cytokines), keeping untreated cancer cells as a control.